OncoAlert
@OncoAlert
Followers
39K
Following
119K
Media
4K
Statuses
108K
🌐 Worldwide Network of Oncology Professionals & Patient Advocates with the common goal of ending cancer, we are Oncology360 degrees 🌎 We are #OncoAlert 🚨
Worldwide
Joined March 2019
The OncoAlert WEEKLY RoundUp 🚨 .Covering the TOP of the week July 25-31, 2025 . 👉REGISTER at OR . Discussing: .✅Biomarkers🧬of response and resistance to immune checkpoint inhibitors in #BreastCancer by @LoiSher . ✅POETIC
0
15
35
RT @JankovicK: 🚨 Phase II trial in #SCLC & 1–10 brain mets: 🧠. SRS/SRT showed low neurologic death (11%) 🆚 historical WBRT (17.5%), with on….
ascopubs.org
PURPOSEStereotactic radiation (SRS/SRT) as opposed to whole-brain radiation (WBRT) represents the standard of care for patients with a limited number of brain metastases given the relatively favora...
0
1
0
RT @JGeriOnc: Variation in bone health management in older women with breast cancer: A secondary analysis of the Age Gap study https://t.co….
0
2
0
RT @nataliagandur: 🌟🧬 Bladder Cancer & the Microbiome: A New Frontier. ✍️ Zhiwen Luo, @CoderDoge1108, Hantao Wang, Jianing Fu, Yiqiang Zhan….
0
5
0
RT @CACancerJournal: 🧬 Genomic-guided cancer care is not just precision medicine—it’s a public health imperative. CA guidelines simplify c….
0
1
0
RT @JournalCancer: Self-management focused follow-up in the LETSGO study showed improved emotional, social, and physical wellbeing in gynec….
0
2
0
RT @OncoAlert: Experience the 2025 International Symposium of Gastrointestinal Oncology (ISGIO) LIVE in Austin Tx or Streamed ONLINE ! Join….
0
14
0
RT @OncoAlert: Quantitative assessment of HER2 expression in invasive ductal carcinoma and co-existing DCIS . . Thi….
0
9
0
RT @MarioBalsaMD: 🧬 Prospective data on the impact of PAM50-based Prosigna in neoadj. planning for HR+/HER2– early breast cancer (n=54).htt….
esmoopen.com
The 50-gene assay Prosigna is cleared by the United States Food and Drug Administration only in postoperative hormone receptor-positive (HR-positive) breast cancer (BC) specimens. Given studies...
0
3
0
RT @DrYukselUrun: Phase 2 trial shows FAPI-PET–CT is safe, reproducible & highly accurate for detecting FAP+ tumours (PPV 90%). ☢️Next step….
0
10
0
RT @OncoAlert: Early-Onset Gastrointestinal Cancers . . Early-onset gastrointestinal (GI) cancers—diagnosed in indi….
0
14
0
RT @OncoAlert: Impact of the Prosigna assay on neoadjuvant treatment decision-making in patients with early-stage HR-positive/HER2-negative….
0
15
0
RT @OncoAlert: Now on Demand: Virtual Webinar on the latest in #BreastCancer from #ASCO25! by @vjoncology. WATCH HERE 👉 .
0
5
0
RT @DrFelixGuerrero: 🚨 JUST PUBLISHED in @JCM_MDPI @MDPIOpenAccess .🔬 Detailed overview of the current research landscape in perioperative….
0
5
0
RT @mirrorsmed: Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting #immunotherapy efficacy. https://t.….
0
4
0
RT @APCCC_Lugano: Precision and Combination Strategies for Immune Checkpoint Inhibitors in Prostate Cancer. Edito….
0
11
0
RT @MarioBalsaMD: 💥 New @NatureRevCancer dives deep into #SCLC: ▪️Lineage shifts, immune evasion, epigenetic rewir….
nature.com
Nature Reviews Cancer - In this Review, Simpson et al. summarize the emergent understanding of molecular subtypes of small cell lung cancer (SCLC). They discuss how intratumour heterogeneity and...
0
5
0
RT @Lucarecco: If you'll be in Berlin for the #ESMO25 annual meeting, join the super @OncoAlert #Oncoalert5k run starting at the Brandenbur….
0
3
0
RT @OncoAlert: Join us for the 44th Annual Congress of the European Society of Surgical Oncology (ESSO 44) @ESSOnews Gothenburg, Sweden🇸🇪….
0
9
0
Stereotactic Radiosurgery in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases: A Multi-Institutional, Phase II, Prospective Clinical Trial . . This multicenter, single-arm phase II trial evaluated stereotactic radiosurgery/radiotherapy
0
10
21